Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    "Shigellosis"
Show Display Options
Rank Status Study
21 Completed Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate
Conditions: Dysentery;   Shigella;   Diarrhea
Interventions: Biological: WRSS1 vaccine;   Biological: Placebo vaccine
22 Active, not recruiting Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
Conditions: Soil-transmitted Helminthiasis;   Schistosomiasis;   Strongyloidiasis;   Shigellosis;   Intestinal Salmonellosis;   Campylobacteriosis;   Aeromonas Spp. Infections;   Giardiasis;   Amoebiasis;   Dientamoebiasis;   Cryptosporidium Spp. Infections
Interventions: Procedure: Stool culturing for pathogenic bacteria;   Procedure: Kato-Katz technique;   Procedure: Baermann technique;   Device: Mini-FLOTAC;   Device: Crypto/Giardia Duo Strip;   Procedure: Formalin-ether concentration technique;   Device: CCA RDT;   Procedure: Koga agar plate culture;   Procedure: Kinyoun staining;   Device: Multiplex PCR;   Procedure: Metagenomics analysis
23 Not yet recruiting Shigella WRSS1 Vaccine Trial in Bangladesh
Condition: Diarrhea
Intervention: Biological: WRSS1
24 Completed Safety Study of Live Shigella Vaccine in Bangladeshi Adults and Children
Condition: Diarrhea
Intervention: Biological: WRSS1
25 Not yet recruiting Shigella Sonnei 53G Challenge
Condition: Healthy
Intervention: Biological: Shigella sonnei 53G
26 Completed Zinc Supplementation in Shigella Patients
Condition: Testing Effect of Intervention
Intervention: Drug: Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.
27 Unknown  A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals
Conditions: Viral Pneumonia;   Bronchitis;   Infantile Diarrhea;   Bacillary Dysentery;   Virus Hepatitis
28 Completed Invaplex 50 Vaccine Dose-Ranging
Condition: Diarrhea
Intervention: Biological: Shigella flexneri 2a Invaplex 50
29 Unknown  Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections
Condition: Dysentery
Intervention: Other: Laboratory Tests
30 Completed Rifaximin for Prevention of Travellers' Diarrhea
Condition: Diarrhea
Interventions: Drug: Rifaximin;   Drug: Placebo
31 Recruiting Phase 1 Study of dmLT ID Vaccination in Healthy Adults
Condition: Gastroenteritis Escherichia Coli
Interventions: Other: Placebo;   Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-31) Next Page   
Indicates status has not been verified in more than two years